Our integrative approach using network pharmacology and bioinformatics predicts that targeting the PIK3R1 gene and modulating the PI3K/Akt signaling pathway can ameliorate obesity. This evidence concerns the gene AKT1 and obesity due to melanocortin 4 receptor deficiency.